Pathology Doctors in Grosse Pointe Woods, MI Accepting Medicare

2 Pathology doctors found. Showing 1 - 2

Daniel Matthew Ockner, MD Pathology - Anatomic Pathology Medicare: Medicare Enrolled Practice Location: 22151 Moross Road, Sjhmc-department Of Pathology, Grosse Pointe Woods, MI 48236 Phone: 313-343-3520    Fax: 313-881-4727

Paul John Kowalski, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 22101 Moross Road, Sjhmc-department Of Pathology, Grosse Pointe Woods, MI 48236 Phone: 313-343-3520    Fax: 313-881-4727

News Archive

RD Biomed announces Chinese distribution agreement for reflux diagnostic tool Peptest

RD Biomed, the Yorkshire medical technology company, has announced a Chinese distribution agreement for its world-leading reflux diagnostic tool Peptest.

COBRA, jobs bill in further jeopardy after death of Sen. Byrd

Roll Call: The death of Sen. Robert Byrd, D-W. Va., has jeopardized further the passage of some bills in Congress, including a bill that would extend unemployment benefits. "Democratic leaders have been thwarted numerous times in recent weeks on jobs legislation, despite scaling down the measure dramatically after Republicans and some moderate Democrats balked at adding to the deficit.

Researchers identify ways to predict patients with small-cell lung cancer

Researchers for TGen Clinical Research Services at Scottsdale Healthcare (TCRS) have identified a way to predict which patients with small-cell lung cancer may be resistant to first-line chemotherapy.

Trinity researchers reveal CHD5 protein acts as tumor suppressor in nervous system development

CHD5 has previously been proposed as a tumour suppressor, acting as a brake that prevents healthy cells from developing into cancer cells. But the part played by the protein in healthy tissue, and whether this role is important for its ability to counter tumour growth, has remained largely uncharted.

Meta-analysis study shows association between BTMs s-CTX, s-PINP and risk of future fractures

​A new study by an International Osteoporosis Foundation (IOF) and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) scientific working group summarizes the clinical performance of serum procollagen type I N propeptide (s-PINP) and serum C-terminal cross-linking telopeptide of type I collagen (s-CTX) in fracture risk prediction in untreated individuals in prospective cohort studies.

Read more Medical News

› Verified 3 days ago